A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

NCT06672549 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

125

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity
Overweight

Interventions

DRUG: Orforglipron
DRUG: Placebo

Sponsor

Eli Lilly and Company